Oliver Harschnitz - Publications
Affiliations: | Sloan Kettering Institute, New York, NY, United States |
Year | Citation | Score | |||
---|---|---|---|---|---|
2018 | van Rheenen W, Diekstra FP, Harschnitz O, Westeneng HJ, van Eijk KR, Saris CGJ, Groen EJN, van Es MA, Blauw HM, van Vught PWJ, Veldink JH, van den Berg LH. Whole blood transcriptome analysis in amyotrophic lateral sclerosis: A biomarker study. Plos One. 13: e0198874. PMID 29939990 DOI: 10.1371/journal.pone.0198874 | 0.447 | |||
2016 | van Rheenen W, Shatunov A, Dekker AM, McLaughlin RL, Diekstra FP, Pulit SL, van der Spek RA, Võsa U, de Jong S, Robinson MR, Yang J, Fogh I, van Doormaal PT, Tazelaar GH, Koppers M, ... ... Harschnitz O, et al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nature Genetics. 48: 1043-8. PMID 27455348 DOI: 10.1038/Ng.3622 | 0.375 | |||
2014 | van den Heuvel DM, Harschnitz O, van den Berg LH, Pasterkamp RJ. Taking a risk: a therapeutic focus on ataxin-2 in amyotrophic lateral sclerosis? Trends in Molecular Medicine. 20: 25-35. PMID 24140266 DOI: 10.1016/j.molmed.2013.09.001 | 0.543 | |||
Show low-probability matches. |